Alpha Teknova Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 94/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 9.00.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Alpha Teknova Inc's Score
Industry at a Glance
Industry Ranking
94 / 208
Overall Ranking
223 / 4578
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
6
analysts
Buy
Current Rating
9.000
Target Price
+96.51%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Alpha Teknova Inc Highlights
StrengthsRisks
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary product categories, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. It supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.
Growing
The company is in a growing phase, with the latest annual income totaling USD 37.74M.
Undervalued
The company’s latest PE is -13.37, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 45.32M shares, decreasing 3.55% quarter-over-quarter.
Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary product categories, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. It supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.
Ticker SymbolTKNO
CompanyAlpha Teknova Inc
CEOGunstream (Stephen)
Websitehttps://www.teknova.com/
FAQs
What is the current price of Alpha Teknova Inc (TKNO)?
The current price of Alpha Teknova Inc (TKNO) is 4.460.
What is the symbol of Alpha Teknova Inc?
The ticker symbol of Alpha Teknova Inc is TKNO.
What is the 52-week high of Alpha Teknova Inc?
The 52-week high of Alpha Teknova Inc is 10.370.
What is the 52-week low of Alpha Teknova Inc?
The 52-week low of Alpha Teknova Inc is 3.940.
What is the market capitalization of Alpha Teknova Inc?
The market capitalization of Alpha Teknova Inc is 238.72M.
What is the net income of Alpha Teknova Inc?
The net income of Alpha Teknova Inc is -26.75M.
Is Alpha Teknova Inc (TKNO) currently rated as Buy, Hold, or Sell?
According to analysts, Alpha Teknova Inc (TKNO) has an overall rating of Buy, with a price target of 9.000.
What is the Earnings Per Share (EPS TTM) of Alpha Teknova Inc (TKNO)?
The Earnings Per Share (EPS TTM) of Alpha Teknova Inc (TKNO) is -0.334.